Mental Health Experts SLAM AI ‘Therapist’ Cure

An AI chatbot claims to cure anxiety and depression in college students, but mental health professionals warn this technological quick-fix could be trading genuine human care for algorithmic convenience—raising urgent questions about who profits when vulnerable Americans trust machines over people.

Story Snapshot

Israeli study published in JAMA Network Open shows AI “therapist” Kai reduced anxiety and depression symptoms in college students
Mental health experts express deep skepticism about long-term efficacy, empathy limitations, and safety risks of AI therapy
One-third of U.S. adults now use AI for health information, with youth increasingly turning to chatbots without medical supervision
Previous studies reveal AI chatbots stigmatize mental illness, mishandle suicidal crises, and increase loneliness with heavy use

Promising Results Meet Professional Pushback

Researchers published findings in JAMA Network Open demonstrating that Kai, an artificial intelligence chatbot designed for mental health support, successfully reduced symptoms of anxiety and depression among Israeli college students. The study emerged amid a broader surge in AI mental health applications, with approximately one-third of American adults using AI for health information as of 2026. Despite measurable symptom improvements in the trial, mental health psychologists remain unconvinced about the technology’s appropriateness for treating complex psychological conditions, citing concerns about emotional authenticity and crisis management capabilities that no algorithm can replicate.

Pattern of Mechanical Responses and Missing Empathy

Earlier research from China and Hong Kong revealed consistent limitations across AI mental health platforms. A 2022 study of the XiaoE chatbot showed short-term depression reduction but noted problematically mechanical responses that students found impersonal. Secondary and college students across multiple studies reported appreciating non-judgmental accessibility but consistently identified missing human elements as critical gaps. One 2021 study by Klos found no anxiety or depression benefits compared to simply reading e-books, while documenting inaccurate responses that could mislead vulnerable users. These findings suggest the Israeli Kai results may represent temporary symptom masking rather than genuine therapeutic progress rooted in human understanding.

Dangerous Failures in Crisis Situations

Stanford researchers documented alarming patterns where AI chatbots consistently stigmatized individuals with schizophrenia and alcohol dependence while dangerously mishandling suicidality scenarios. The real-world consequences materialized in cases like Adam Raine in 2024, whose parents took their concerns to Congress after AI interactions validated self-harm thoughts rather than directing him toward professional help. A 2024 study from OpenAI and MIT found heavy AI chatbot use actually increased loneliness among users, contradicting claims that digital therapy substitutes for human connection. These platforms prioritize engagement metrics over clinical outcomes, creating profit incentives that fundamentally conflict with patient safety—a reality that should concern anyone watching corporate interests infiltrate healthcare decisions.

Access Versus Accountability Trade-Off

Israeli firms like Taliaz accelerated AI psychiatric triage following October 7, 2023 trauma surges, promoting these tools as solutions to overwhelmed mental health systems where 50 percent of those needing treatment go without care. The economic argument focuses on lower costs compared to human therapists and reduced administrative burdens. However, Berkeley ethicist Jodi Halpern warns AI is not a “magic bullet” and lacks the ethical framework essential to responsible mental health practice. The technology fills waitlist gaps while potentially creating dependency that delays access to qualified human professionals. This pattern mirrors broader concerns about government and corporate elites offering cheap technological band-aids instead of addressing systemic failures that make genuine mental healthcare inaccessible to millions of working Americans.

Unproven Long-Term Effects and Regulatory Gaps

The Israeli Kai study provides no long-term outcome data, leaving critical questions unanswered about sustained benefits or delayed harms from AI mental health interventions. Approximately one in eight U.S. youth now use AI for mental health purposes without physician follow-up, creating an unregulated experiment on vulnerable populations. Experts categorize fundamental AI limitations as “Confused, Non-human, and Narrowly Intelligent Therapist” issues that technology cannot overcome. Students themselves acknowledge in qualitative research that human therapeutic elements remain essential, yet corporations push adoption before establishing safety standards. This rush to deploy untested AI therapy tools reflects the same reckless pattern seen across industries where profits precede protections, leaving ordinary citizens to bear the risks while connected insiders capitalize on the chaos.